HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin

被引:2
作者
Rugo, H. [1 ]
Barve, A. [2 ]
Waller, C. [3 ]
Bronchud, M. H. [4 ]
Herson, J. [5 ]
Yuan, J. [6 ]
Manikhas, A. [7 ]
Bondarenko, I. [8 ]
Mukhametshina, G. [9 ]
Nemsadze, G. [10 ]
Parra, J. [11 ]
Tiambeng, M. L. Abesamis [12 ]
Baramidze, K. [13 ]
Akewanlop, C. [14 ]
Vynnychenko, I. [15 ]
Sriuranpong, V. [16 ]
Mamillapalli, G. [17 ]
Ray, S. [18 ]
Yanez Ruiz, E. P. [19 ]
Pennella, E. [2 ]
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Mylan, Global Clin Res, Canonsburg, PA USA
[3] Univ Freiburg, Dept Innere Med, Freiburg, Germany
[4] Hosp Univ Dexeus, Quiron Grp, Barcelona, Spain
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Chevy Chase, MD USA
[6] Mylan, Dept Biostat, Canonsburg, PA USA
[7] City Clin Oncol Dispensary, St Petersburg, Russia
[8] Dnipropetrovsk State Med Acad, Dept Med, Dnepropetrovsk, Ukraine
[9] Reg Clin Oncol Ctr, Dept Med, Kazan, Russia
[10] Inst Clin Oncol, Dept Oncol, Tbilisi, Georgia
[11] St Lukes Med Ctr, Dept Med, Taguig City, Philippines
[12] Cardinal Santos Med Ctr, Inst Canc, Manila, Philippines
[13] Golden Fleece 21 Century Hlth House Ltd, Dept Oncol, Tbilisi, Georgia
[14] Siriraj Hosp, Med Oncol Unit, Dept Med, Bangkok, Thailand
[15] Sumy State Univ, Sumy Reg Oncol Ctr, Sumy, Ukraine
[16] King Chulalongkom Mem Hosp, Dept Oncol, Bangkok, Thailand
[17] City Canc Ctr, Dept Oncol, Vijayawada, India
[18] Curie Manavata Canc Ctr, Dept Oncol, Nasik, India
[19] Inst Clin Oncol Sur, Dept Oncol, Temuco, Chile
关键词
D O I
10.1016/S0959-8049(17)30216-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
255
引用
收藏
页码:S41 / S41
页数:1
相关论文
empty
未找到相关数据